Mitsubishi Tanabe, Keio University Tie Up for Research of Neutralizing Antibodies for COVID-19

Mitsubishi Tanabe Pharma has said that it has entered into a research collaboration deal with Keio University for neutralizing antibodies for the treatment of COVID-19. Tsutomu Takeuchi, professor at the rheumatology division, Department of Internal Medicine at Keio University School...read more